Equities

Dswiss Inc

DQWS:PKC

Dswiss Inc

Actions
  • Price (USD)0.0125
  • Today's Change0.00 / 0.00%
  • Shares traded76.00
  • 1 Year change-91.67%
  • Beta--
Data delayed at least 15 minutes, as of Apr 23 2024 20:48 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

DSwiss, Inc. is a biotech nutraceutical company that offers healthcare, skincare, and personal care products. The Company sells medical consumable supplies, food supplements, skincare, and other related beauty products in Malaysia and around the ASEAN region. The Company is a turnkey private label manufacturing services provider for nutraceutical and skincare/personal care original design manufacturer (ODM)/ original equipment manufacturer (OEM) products. It provides ODM/OEM services ranging from research and development of custom formulation, manufacturing and production, packaging and shipping including import and export and all licenses needed. It also provides lab testing and quality control services. Its products and formulations include functional food, skincare, personal care and pet-care. Its personal care products include cosmetics, shower gel and lotion. It provides food supplement in different forms such as chewable tablets, jellies, teabags, capsules and gummies.

  • Revenue in USD (TTM)1.47m
  • Net income in USD-49.54k
  • Incorporated2015
  • Employees11.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Panacea Life Sciences Holdings Inc2.38m-8.02m2.44m40.00------1.02-0.4882-0.48820.145-0.46990.12731.5310.1559,624.00-42.78-69.04-543.23-225.03-171.48-181.62-336.08-505.410.0331-2.093.29--46.59--12.33------
Sonoma Pharmaceuticals Inc12.31m-5.08m2.48m9.00--0.3251--0.2016-0.9608-0.96081.950.4890.86252.584.761,367,778.00-35.56-37.52-47.14-51.3539.1740.17-41.23-37.123.11--0.0065--5.10-4.44-1.28--7.54--
Qrons Inc0.00-789.36k2.53m2.00---------0.0581-0.05810.00-0.1090.00----0.00-45,235.53-1,513.45---------------5.76---------7.61------
Agile Therapeutics Inc19.59m-14.47m2.54m19.00------0.1295-9.84-9.849.11-5.511.604.415.791,031,158.00-118.12-94.24---142.6254.18---73.85-513.500.3269------80.02--43.08------
DSwiss Inc1.47m-49.54k2.59m11.00--45.84157.511.76-0.0002-0.00020.00710.00033.92154.8254.81133,643.60-13.22-8.69-50.26-45.4724.4425.55-3.37-2.471.05-15.740.3961---20.5046.20-688.36---66.17--
Eloxx Pharmaceuticals Inc0.00-20.48m2.59m18.00---------9.06-9.060.00-6.530.00----0.00-124.43-115.27---155.33-----------16.69--------45.95---22.56--
GB Sciences Inc0.00-4.03m2.60m3.00---------0.0105-0.01050.00-0.01190.00----0.00-255.86-49.16---131.40--6.03---995.19---8.63---------2,715.25---60.82--
Regen BioPharma Inc236.58k-772.29k2.63m1.00------11.10-0.3564-0.35640.0658-1.400.8248--3.29236,580.00-289.03-104.36---------350.41-275.00---1.48----0.441618.79-58.11------
Onconetix Inc58.47k-37.41m2.66m12.00------45.44-2.09-2.090.00342.630.001--0.63014,872.50-65.73---87.29---1,927.76---63,981.00--0.3185-19.880.1292-------176.78------
Transcode Therapeutics Inc0.00-18.55m2.67m10.00--0.1759-----473.31-473.310.002.620.00----0.00-290.74-133.14-753.94-181.26-----------383.690.00-------5.59------
cbdMD Inc23.45m-23.98m2.77m52.00--1.03--0.1182-20.34-20.3412.190.88390.92272.0623.44450,876.20-78.62-38.59-101.68-41.5063.8463.80-85.21-87.980.6383-9.920.00---31.77120.9163.64---4.95--
NovaBay Pharmaceuticals Inc14.73m-16.70m2.78m24.00--0.634--0.1886-3.82-3.823.500.29511.162.1610.78613,583.30-75.81-61.51-114.10-83.8953.6159.99-65.46-86.470.9998--0.2555--2.243.32-2.66---15.46--
Twinlab Consolidated Holdings Inc13.62m-9.66m2.79m17.00------0.2045-0.0373-0.05290.0526-0.53660.91061.344.41801,000.00-64.61-60.53----36.8121.36-70.96-37.720.0157-0.0516-----20.87-28.58-20.28------
ENDRA Life Sciences Inc0.00-10.06m2.81m21.00--0.4671-----1.93-1.930.000.54470.00----0.00-125.53-132.00-149.91-157.28------------0.005------23.67---19.46--
Data as of Apr 23 2024. Currency figures normalised to Dswiss Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.